The impact of the COVID-19 pandemic on skin cancer incidence and treatment in England, 2020
Br J Dermatol
.
2021 Aug;185(2):460-462.
doi: 10.1111/bjd.20409.
Epub 2021 May 31.
Authors
Z C Venables
1
2
,
S Ahmed
3
,
T O Bleiker
3
4
,
J Broggio
2
,
M Kwiatkowska
2
3
,
N J Levell
1
,
G W M Millington
1
3
,
L Paley
2
,
E Payne
2
,
C M Proby
5
,
S Vernon
2
,
S McPhail
2
Affiliations
1
Norfolk and Norwich University Hospital, Norwich, UK.
2
National Cancer Analysis and Registration Service, Public Health England, London, UK.
3
British Association of Dermatologists, London, UK.
4
University Hospital of Derby and Burton NHS Foundation Trust, Derby, UK.
5
Ninewells Hospital & Medical School, University of Dundee, Dundee, UK.
PMID:
33937975
PMCID:
PMC8239907
DOI:
10.1111/bjd.20409
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
England / epidemiology
Humans
Incidence
Pandemics
SARS-CoV-2
Skin Neoplasms* / epidemiology